Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nurtec
Pharma
Pfizer pays $60M to resolve Biohaven's Nurtec kickback claims
Pfizer—which bought Biohaven in 2022—is commiting more than $59.7 million to resolve kickback allegations tied to migraine med Nurtec.
Fraiser Kansteiner
Jan 27, 2025 10:39am
The top 10 Fierce Pharma Marketing stories of 2024 recapped
Dec 23, 2024 5:00am
BMJ says newer migraine drugs less effective than older triptans
Sep 19, 2024 11:32am
AbbVie's Ubrelvy fares well warding off migraines in study
Aug 29, 2024 11:58am
The top 10 pharma drug ad spenders for 2023
Jun 3, 2024 3:00am
Lady Gaga's post about Pfizer Nurtec ODT ad earns EU ire
Apr 12, 2024 12:07pm
